Invesco FTSE RAFI US 1000 UCITS ETF Dist is a equity ETF from Invesco tracking the FTSE RAFI US 1000 index through physical replication. Domiciled in Ireland and launched in 2007, the fund manages about 891 M € and charges a TER of 0.39% — 39 € per year on a €10,000 investment. Income is paid out to investors periodically (distributing).
Invesco FTSE RAFI US 1000 UCITS ETF Dist competes with 359 other products in the same class and region (Equity, USA): it ranks 118th by fund size and 315th by ongoing cost, with a TER of 0.39% against a group median of 0.20%. It has been listed since 2007, 19 years of track record.
On a €10,000 investment the TER costs 39 € a year, against 20 € for the median product in the category.
Replication is physical: the fund holds the underlying securities directly. The ten largest positions account for 24.9% of the portfolio.
Income is distributed periodically: it produces cash flow, but reinvesting it is up to you if the goal is capital growth. The fund is denominated in EUR. That is not the same as currency risk: the exposure comes from the currencies of the underlying holdings, not from the denomination or the trading currency of a given listing.
Irish domicile lets the fund apply the Ireland–US tax treaty, with 15% withholding instead of 30% on US dividends received by the fund.
| Apple Inc. | 4.5% |
| Alphabet Inc Class A | 4.1% |
| Intel Corporation | 3.0% |
| Microsoft Corporation | 2.3% |
| Amazon.com Inc | 2.3% |
| Berkshire Hathaway Inc | 2.0% |
| Exxon Mobil Corp | 1.9% |
| JPMorgan Chase & Co | 1.8% |
| Meta Platforms Inc. | 1.5% |
| UnitedHealth Group Incorporated | 1.5% |
| Borsa Italiana | PFT | EUR |
| XETRA | 6PSA | EUR |
| Francoforte | 6PSA | EUR |
| London Stock Exchange | PSRF | GBX |
| London Stock Exchange | PRUS | USD |
| Euronext Paris | PFT | EUR |
| SIX Swiss Exchange | PFT | USD |
Source: the fund's KID and the issuer's official documentation — data verified as of July 2026.
This page is informational and is not an investment recommendation. Figures may contain errors or be out of date: always check the KID and the issuer's factsheet before any decision.